Financhill
Back

Keros Therapeutics Stock Predictions

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 1.7% based on the past 5 years of stock performance.
  • Keros Therapeutics has fallen lower in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $13.56. The Score for KROS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 1.7% based on the past 5 years of stock performance.

Keros Therapeutics Stock Rating

Sell
14
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has fallen lower in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
72.37
52-Week Low:
9.12

Prediction Charts

Market Cap:
550.7M
Price in USD:
13.56
Volume:
377.9K
Beta:
1.19

Technical Analysis

SMA50:
13.64
SMA100:
12.37
SMA200:
30.03
52-Wk Change:
-72.61%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 13.56 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-27 14.63 14.35 14.69 14.17
May-28 14.45 14.64 14.91 14.37
May-29 14.41 14.02 14.54 13.81
May-30 14.01 14.15 14.33 13.77
Jun-2 14.15 14.66 14.79 14.15
Jun-3 14.75 14.95 15.20 14.59
Jun-4 14.94 14.82 15.17 14.76
Jun-5 14.82 15.11 15.23 14.64
Jun-6 15.18 15.04 15.40 14.93
Jun-9 14.20 14.09 15.14 14.00
Jun-10 13.78 13.75 14.02 13.50
Jun-11 13.96 13.79 14.05 13.71
Jun-12 13.72 13.64 14.00 13.54
Jun-13 13.49 13.56 13.84 13.34

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.